Muraoka and colleagues reported that brain-derived EVs carry a higher level of signature proteins Aβ and tau and glial-specific molecules such as ANXA5, VGF, GPM6A, and ACTZ in AD patients compared with control subjects [118]. The gene discussed is GPM6A; the disease is Alzheimer disease.